Related Experiment Video
Updated: Aug 30, 2026

A Modified Inflammatory Pain Model to Study the Analgesic Effect in Mice
Published on: November 15, 2024
Sweet taste and blood pressure-related analgesia
Maxim D Lewkowski1, Blaine Ditto, Marios Roussos
1Department of Psychology, McGill University, 1205 Dr Penfield Avenue, Montreal, Que., Canada H3A 1B1. maxim.lewkowski@mail.mcgill.ca
Abstract:
To test the prediction that sweet taste modifies responses to cold induced pain, 72 young adults held sweet, bitter and water solutions in their mouths, in counterbalanced order, before and during a cold pain stimulus. To test whether or not blood pressure interacts with sweet taste analgesia, measurements of resting blood pressure were also obtained. A significant main effect of taste on pain tolerance was observed, as well as a significant interaction between resting mean arterial pressure (MAP) and taste on tolerance. Sweet taste was associated with a prolongation of tolerance compared to the bitter and water conditions. When participants were split along the median for MAP, sweet taste was associated with an 18.1% increase in pain tolerance compared with water for those with lower MAP. No significant impact of taste on pain sensitivity was observed among participants with higher MAP. Groupwise comparisons revealed a significant difference in pain tolerance between participants with higher and lower MAP in the water condition but not in the sweet condition, replicating previous findings of a reduced sensitivity to pain among those with higher blood pressure. The analgesic effects of sweet tasting solutions seen previously in human infants and children may also be present in adults. Individuals with higher blood pressure may not be as sensitive to the presumably opioid-mediated analgesic effects of sweet taste, perhaps due to opioid dysregulation.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
The Physiology of Taste
Pain
Opioid Analgesics: Morphine and Other Natural Cogeners
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
